Tagged: USAN

Genprex Receives USAN Approval of Non-Proprietary Name for Lead Drug Candidate

Company executes on corporate communication strategy and advances drug branding initiatives

Read More

Genprex Begins Next Phase of Drug Branding Program

Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company, today announced it has initiated the first phase of branding its lead drug candidate, Oncoprex™ immunogene therapy, and has completed the creation and submission of non-proprietary drug name selections to the American Medical Association’s United States Adopted Names (USAN) Council.

Read More